D.E. Shaw & Co’s LakeShore Biopharma Warrants LSBPW Stock Holding History

D.E. Shaw & Co’s Portfolio LSBPW Stock Details LSBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-100,000	Closed	-$4K	–	4993
2025 Q2	$4K	Hold	100,000	–	–	﹤0.01%	4281
2025 Q1	$4.13K	Hold	100,000	–	–	﹤0.01%	4165
2024 Q4	$9.9K	Hold	100,000	–	–	﹤0.01%	4279
2024 Q3	$4.94K	Hold	100,000	–	–	﹤0.01%	4427
2024 Q2	$9.25K	Hold	100,000	–	–	﹤0.01%	4316
2024 Q1	$5.1K	Hold	100,000	–	–	﹤0.01%	4221
2023 Q4	$2.71K	Hold	100,000	–	–	﹤0.01%	4214
2023 Q3	$3.5K	Hold	100,000	–	–	﹤0.01%	4160
2023 Q2	$4.7K	Hold	100,000	–	–	﹤0.01%	4114
2023 Q1	$15.6K	Buy	+100,000	New	+$15.2K	﹤0.01%	4177

Other funds holding LSBPW

HIM

HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

D.E. Shaw & Co's LSBPW Position: Q3 2025 in Review

D.E. Shaw & Co sold out of LakeShore Biopharma Warrants (LSBPW) in Q3 2025, closing a stake of 100,000 shares — an estimated $4K sold.

D.E. Shaw & Co first reported a position in LSBPW in Q1 2023 and held it in 10 quarters. The position peaked at $15.6K in Q1 2023. 3 funds tracked by Wall St. Rank hold LSBPW as of Q3 2025.

D.E. Shaw & Co reported no remaining LakeShore Biopharma Warrants position as of Q3 2025 after selling out during the quarter.
D.E. Shaw & Co sold 100,000 LakeShore Biopharma Warrants shares in Q3 2025, an estimated $4K.
D.E. Shaw & Co first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 10 quarters.
D.E. Shaw & Co's LakeShore Biopharma Warrants position peaked at $15.6K in Q1 2023.
3 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q3 2025.

Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.